Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
Beliebteste Broker
News
- 07.10. - 12:40 Uhr
Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and Parts of Central and South America
Toronto, Ontario--(Newsfile Corp. - October 7, 2024) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma") provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu" or the "Company"), and its launching of unbuzzd™, an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, minerals and botanical extracts designed to support the body's natural processes for metabolizing alcohol and promoting alertness. » Mehr auf newsfilecorp.com
- 07.10. - 11:30 Uhr
Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and parts of Central and South America
TORONTO, ON / ACCESSWIRE / October 7, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu" or the "Company"), and its launching of unbuzzd™, an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, minerals and botanical extracts designed to support the body's natural processes for metabolizing alcohol and promoting alertness. » Mehr auf accesswire.com
- 28.09. - 00:06 Uhr
Quantum Biopharma Provides Corporate Update
TORONTO, ON / ACCESSWIRE / September 27, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce the following corporate updates. » Mehr auf accesswire.com
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 9,84 Mio € |
Anzahl Aktien | 1,86 Mio |
52 Wochen-Hoch/Tief | 89,87 € - 3,23 € |
Dividenden | Nein |
Beta | 0,83 |
KGV (PE Ratio) | 0,00 |
KGWV (PEG Ratio) | 0,00 |
KBV (PB Ratio) | 0,00 |
KUV (PS Ratio) | 0,00 |
Unternehmensprofil
Name | Quantum BioPharma Aktie |
CEO | Zeeshan Saeed |
Mitarbeiter | 0 |
Ticker Symbole
Börse | Symbol |
---|---|
München | 0K91.MU |
Assets entdecken
Shareholder von Quantum BioPharma Aktie investieren auch in folgende Assets